Polyrizon Ltd. balance sheet PLRZ

Annual Quarterly

As of Dec 31, 2025, Polyrizon Ltd. had total assets of $21.4 million. Total assets were up 286.5% from a year earlier. Stockholders' equity was $21.0 million. Cash and investments were $1.3 million. The current ratio, current assets divided by current liabilities, was 29.03.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
Assets
Cash
1
-48.9%
3
Cash and investments
1
-49.6%
3
Total current assets
13
+384.7%
3
Property and equipment, net
0
+20.0%
0
Total assets
21
+286.5%
6
Liabilities and equity
Total current liabilities
0
+69.7%
0
Stockholders' equity
21
+297.2%
5
Ratios
Current ratio
29.03x
10.16x
Return on equity
-15.89%
-29.23%
Return on assets
-15.56%
-27.85%
Book value per share
13.05
1,890.56
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PLRZ (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ra'Anana
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1893645

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.